Form 8-K - Current report:
SEC Accession No. 0000078003-24-000130
Filing Date
2024-07-10
Accepted
2024-07-10 16:11:00
Documents
14
Period of Report
2024-07-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K pfe-20240709.htm   iXBRL 8-K 29530
  Complete submission text file 0000078003-24-000130.txt   192341

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pfe-20240709.xsd EX-101.SCH 2737
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pfe-20240709_def.xml EX-101.DEF 15360
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pfe-20240709_lab.xml EX-101.LAB 27449
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pfe-20240709_pre.xml EX-101.PRE 16027
16 EXTRACTED XBRL INSTANCE DOCUMENT pfe-20240709_htm.xml XML 4273
Mailing Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192
Business Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192 2127332323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

EIN.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-03619 | Film No.: 241110073
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)